{"id":11647,"name":"Neo-Antigen Therapy Risk Analyzer","purpose":"A software platform that assesses the risks associated with emerging neoantigen therapies, particularly mRNA-based treatments, by analyzing clinical trial data, regulatory guidelines, and public sentiment. It would flag potential naming controversies and liability concerns before they impact market perception.","profitable":1,"date_generated":"Friday April 2026 22:01","reference":"project-neo-risk-analyzer","technology_advise":["Python","Medium","PostgreSQL"],"development_time_estimation_mvp_in_hours":180,"grade":7.8,"category":"healthcare","view_count":4,"similar_ideas":[{"id":11651,"name":"NeoAntigen Treatment Navigator","grade":8.2,"category":"healthcare"},{"id":7606,"name":"mRNA Vaccine Risk Assessment Platform","grade":7.8,"category":"healthcare"},{"id":3163,"name":"AI Regulatory Risk Analyzer","grade":7.8,"category":null},{"id":5171,"name":"AI Risk Predictor","grade":7.3,"category":"ai"},{"id":9492,"name":"Anthropic Risk Navigator","grade":6.5,"category":"devtools"}],"source_headline":"Companies play word games with cancer treatment names."}